337results about How to "Improve curative effect" patented technology

The invention relates to a sodium alginate micro ball vessel suppository which contains soluble medicine, and relative preparation and application, wherein said agent can be divided into two kinds as wet ball and dry ball made from degradable biological material; said carrier comprises sodium alginate, blood serum albumin, chitose, or transparent sodium solution, via the static to be solidified with calcium ion, to be made into the micro ball at 20 mum-1000 mum. The inventive material has high mechanical strength, biological compatibility, biological degradability and stability. The invention can be used to cure the vessel suppository of variable cancers.

The present invention relates to a new-type preparation-oxalibol liposome and its preparation method. It is a liposome or precursor liposome prepared by using oxalibol and auxiliary materials of phospholipid and cholesterol, in which the auxiliary materials of supporting agent, etc. also can be added. The film material phospholipid can adopt natural phospholipid or synthetic phospholipid, and the weight ratio of phospholipid and medicine is 0.1:1-50:1. Its preparation method can adopt ethyl alcohol injection method, film dispersion method, inverted evaporation method, extrusion method and mechanical method, and the supporting agent can be sorbitol, mannitol, cane sugar, sodium chloride, water soluble starch, dextran, glucose and lactose, and the ratio of supporting agent and phospholipid is 0.01:1-500:1. The oxalibol can be used for patient with carcinoma of colon and rectal carcinoma.

The present invention belongs to the field of medicine technology. In particular, it relates to a compound made up by using chitosan, its derivative and low-molecular heparin, its preparation and preparation method. Said compound can raise stability of low-molecular heparin, and can further raise bioavailability of said medicine preparation. Said compound can be made into various oral preparations, injection, spray, nose drops, aerosol and suppository, etc.

The invention discloses a Chinese medicinal composition, particularly a Chinese medicinal composition for treating femoral head necrosis and a preparation method thereof. The Chinese medicinal composition for treating the femoral head necrosis is characterized by comprising the following components: Chinese angelica, white paeony root, red paeony root, Szechuan lovage rhizome, manchurian wildginger, himalayan teasel root, eucommia bark, fortune's drynaria rhizome, twotooth achyranthes root, safflower, peach seed, suberect spatholobus stem, root of red-rooted salvia, rhizoma corydalis, worm, garden balsam stem, common clubmoss herb, pangolin scales, zedoary, dried rehmannia root, frank incense, myrrh, largehead atractylodes rhizome, astragalus, cuttlebone, trogopterus dung, sappan wood, dragon's blood and cornu cervi pantotrichum. The Chinese medicinal composition is specially used for treating femoral head avascular necrosis, femoral head damage, hip joint peripheral damage and necrosis, has an obvious curative effect and high medicinal properties, is used for treating both principal and secondary aspects of diseases, is safe and reliable, and has good effects of eliminating stasis and promoting tissue regeneration, cooling blood to stop bleeding, removing obstruction, smoothing circulation and stopping pain, easing joint movement, diminishing swelling and relieving pain, promoting tissue regeneration, promoting healing, and reuniting muscles and bones. By the Chinese medicinal composition, 860 patients are treated totally, and the total effective rate is 99 percent.

The invention relates to the technical fields of medicament and cosmetics, in particular to a vitamin C proliposome and a preparation method thereof. The vitamin C proliposome can be used for preparing a transdermal preparation and cosmetics. The vitamin C proliposome is a solid granular preparation which ensures that the stabilities of the vitamin C and the proliposome are improved, and the vitamin C proliposome can revert to a vitamin C lipidosome only by adding a small amount of water or aqueous solution for hydration before the vitamin C proliposome is in use, and thereby, a sufficient amount of vitamin C lipidosome is added into the transdermal preparation and the cosmetics according to need so that the content of the vitamin C in the transdermal preparation and the cosmetics reaches the required dosage, and thereby, the efficacy is improved.

A Chinese medicine for treating oral lichen planus is proportionally prepared from 15 Chinese-medicinal materials including honeysuckle flower, red sage root, chinese angelica root, astragalus root, etc.

The invention belongs to the field of traditional Chinese medicines, and especially discloses a traditional Chinese medicine used for treating diarrhea. The traditional Chinese medicine is prepared from active components according to certain weight percentages. The active components are dark plum, tangerine peel, asiatic plantain seed, banksian rose, baikal skullcap root, lobed kudzuvine root, tuckahoe, malt, officinal magnolia bark, Chinese goldthread rhizome, swordlike atractylodes rhizome, angelica archang lica, clove, submature bitter orange, Chinese date, ginger, ma-yuen jobstears seeds,and largehead atractylodes rhizome. The traditional Chinese medicine provided by the invention is specially provided for treating diarrhea. According to the invention, various medicines are appropriately formulated, and the synergism effects or resistance effects of the medicines are adopted for improving the curative effect, such that treatment requirements of complicated pathogenetic conditionsare satisfied. With the traditional Chinese medicine, adverse reactions are reduced, and the curative effect is substantial. The medicine is safe, reliable, and is convenient to take. The medicine provides a good curative effect against diarrhea. Among 860 treated subjects, a total effective rate reaches 97%.

The invention provides a new formulation, namely oil suspension agent, of antiparasitic benzimidazole medicine. The oil suspension agent comprises benzimidazole medicine, a liquid grease, a suspending agent and a wetting agent. The oil suspension agent of benzimidazole medicine provided by the invention is used for treating echinococcosis and other parasitic diseases and can be used for increasing blood concentration and improving curative effects. The oil suspension agent has simple preparation method, good stability and easiness in popularization.

A Chinese medicine 'Xiaotongshu plaster' for treating pain and its preparing process are also disclosed.

The invention relates to a laser therapeutic instrument with laser parameters capable of being modulated automatically and in real time and a using method thereof. The laser therapeutic instrument with laser parameters capable of being modulated automatically and in real time comprises a shell; a laser therapeutic device is arranged outside the shell; and the shell is internally provided with a laser generator device capable of outputting pulse laser with a wavelength of 1064 nm. The laser therapeutic instrument with laser parameters capable of being modulated automatically and in real time ischaracterized by further comprising an intelligent wound surface feature acquisition device, an intelligent wound surface feature recognition device, a laser controller, the laser generator device and the laser therapeutic device which are in mutual signal connection sequentially; and the laser pulse combination parameters which is outputted by the laser generator device and can be modulated automatically and in real time comprise a wavelength of 1064 nm, a laser pulse frequency of 1 to 10 Hz, a laser pulse width of 100 to 400 uS and laser pulse energy of 20 to 300 mJ. The laser outputted bythe laser therapeutic instrument and with the laser pulse combination parameters can be adjusted automatically and in real time, the using method is simple and reliable, and effects are significant.

Disclosed are an extract of ginkgo biloba and a preparation method of the extract. The contents of the controllable components of the liquid phase of the extract reach more than 80 percent; wherein, the content of flavonol glycosides is more than 74 percent; and the content of lactone is more than 6 percent. The preparation method is that extracts of the ordinary ginkgo biloba sold in the market are separated and purified by dephenolization acid, AB-8 resin, polyamide resin and alumina, and then two components containing 90 percent of flavonoids and 50 percent of lactone are respectively made; and the two components are mixed in the proportion of 6: 1. The refined extracts not only can be made into solid oral preparation to reduce the drug dose but also can be made into injection according to the latest requirements of the new drug in the registration provisions in China, and the injection is used to treat cardiovascular and cerebrovascular diseases, taking effect fast.

The invention discloses a Chinese medicine for treating the obstruction of fallopian tubes and adhesion, hydrops and upthrow of fimbriae of fallopian tubes. The Chinese medicine is prepared from 10 to 30 parts of wine-processed root of red-rooted salvia, 10 to 30 parts of wine-processed motherwort herb, 6 to 15 parts of vinegar pangolin scales, 6 to 20 parts of quadruply-processed nutgrass galingale rhizome, 9 to 20 parts of vinegar-processed white paeony root, 6 to 20 parts of red paeony root, 10 to 25 parts of wine-processed full Chinese angelica, 9 to 15 parts of wine-processed chaff flower root, 3 to 10 parts of raw zedoary, 3 to 10 parts of vinegar-processed common burreed rhizome, 6 to 20 parts of prepared rehmannia root and 6 to 10 parts of raw liquoric root which serve as Chinese herbal medicines. The Chinese medicine is used for internal and external treatment, so that the integral treatment of the Chinese medicine is combined with local treatment to enhance a curative effect. According to clinic statistic data, for primary and secondary infertility due to the obstruction of the fallopian tubes or partial smoothness, the adhesion of the fimbriae of the fallopian tubes, the hydrops and the upthrow of the fallopian tubes, pelvic infection and pelvic infection adhesion, the common treatment effect of oral administration, enteroclysis and hot compress is greatly superior to that of individual oral administration or external application of the Chinese medicine.

A chitosan nanopartile (50-200 nm in diameter) used as the carrier of medicine, especially the 5-flurouracil is prepared by microemulsion method. It can be used for researching biological nano-technique, target medicine, cytosis and cancer therapy.

The invention discloses a traditional Chinese medicine for treating senile dementia. The medicine is composed of the following components, by weight: 8-10 parts of Rhodiola rosea, 8-10 parts of Polygala, 10-12 parts of uncaria, 8-10 parts of rhizoma acori graminei, 10-12 parts of Poria cocos, 8-10 parts of concha haliotidis, 10-12 parts of Ganoderma lucidum, 5-8 parts of Ludwigia prostrata, 3-5 parts of pseudo-ginseng, 10-12 parts of angelica, 10-12 parts of Polycarpaea corymbosa, 5-8 parts of scorpion, 10-12 parts of fructus alpiniae oxyphyllae, 5-8 parts of Ligusticum wallichii and 3-5 parts of clove. The traditional Chinese medicine for treating senile dementia provided by the invention has effect of nourishing liver and kidney, tonifying qi and activating blood, benefiting brain and enhancing intelligence, and advantages of good and quick effect on treating senile dementia caused by various causes, low cost, and no side effect.

The invention discloses a conditioned medium which comprises the following components in parts by weight: 0-0.05 part of basic fibroblast growth factor, 0-0.05 part of epidermal growth factor, 94.9-95.9 parts of dulbecco modified eagle medium (DMEM)/ F12, 1 part of antibiotics, 1 part of glutamate, 1 part of non-essential amino acid and 0-1 part of antioxidant. The invention also discloses a cell-activating essence product and a preparation method of the cell-activating essence product. The invention further discloses the application of the cell-activating essence product. The used conditioned medium does not contain animal-based substances, so that the problems of irritability, infection and the like caused by the differences among species can be avoided. Adipose-derived stem cells (ADSCs) are separated by stages by virtue of the mixed enzyme; and the yield of the ADSCs is 3000-5000/ mg. The conditioned medium is used for promoting secretion, so that the content of protein active factor can be increased and the treatment effect of the cell-activating essence product can be improved.

The invention belongs to the technical field of Chinese medicine, and discloses a Chinese medicament for treating viral keratitis, which consists of the following raw materials by weight: 10 to 20 grams of honeysuckle, 15 to 25 grams of weeping forsythae, 7.5 to 15 grams of divaricate saposhnikovia root, 6 to 10 grams of fineleaf schizonepeta herb, 3 to 10 grams of incised notopterygium rhizome, 5 to 9 grams of simpleleaf shrub chastetree fruit, 9 to 15 grams of pale butterflybush flower, 6 to 10 grams of chrysanthemum and 3 to 9 grams of raw licorice root. The Chinese medicament has the characteristics of readily available raw materials, relatively lower cost, good curative effect, quick response, no toxic or side effect, the curative ratio of over 92 percent, and the like.

The invention discloses a genetic evaluation and suit method for individualized tumor therapy. The genetic evaluation and package method includes steps of: 1) extracting a DNA sample of a subject; 2) carrying out target gene PCR amplification, purification, fragmentation and fluorescein labeling on the sample DNA; 3) carrying out gene chip hybridization on fluorescein labeled PCR products to detect SNP sites of the target gene; and 4) analyzing curative effect and toxicity of antitumor drug on the subject, according to the genetic typing results obtained in the step 3). Therapeutic effect evaluation of tumor patient can be conducted through the related genetic typing, thus formulating the most scientific individualized therapy plan to improve efficacy, reduce or even avoid the toxic and side effects.

The invention relates to the field of Chinese medicine formulas, and in particular relates to a Chinese medicine fumigation-washing decoction for treating capecitabine extremities syndrome. The Chinese medicine fumigation-washing decoction is characterized by comprising bulk drugs in parts by weight: 20-30 parts of astragalus membranaceus, 15-20 parts of safflower, 15-20 parts of geranium wilfordii, 12-18 parts of Szechuan lovage rhizome, 12-18 parts of cassia twig, 12-18 parts of herba epimedii, 12-18 parts of common clubmoss herb, 12-18 parts of clematis root, 12-18 parts of incised notopterygium rhizome and 12-18 parts of pubescent angelica root. The ten bulk drugs are mixed and soaked with water, and are decocted and boiled and deslagged to obtain a filter liquid. The Chinese medicine fumigation-washing decoction is low in cost, high in curative effect and has the functions of tonifying qi, promoting blood circulation to remove meridian obstruction, and warming channel and expelling cold to stop pain, and the toxic and side effects are avoided, so that an effect of treating the Capecitabine extremities syndrome is realized well.

The invention discloses an intelligent compression system made by a shape memory material. The intelligent compression system is used for managing or preventing chronic venous insufficiency and comprises a shape memory module, an excitation module for exciting shape memory effect and a control module receiving information fed back by the shape memory module and controlling excitation process. The shape memory module comprises but not limited to textiles, made by the shape memory material and with a certain function structure, like compressed stockings and compressed bandages. The invention further relates to making of shape memory filaments and shape memory modules different in structure. The intelligent compression system has the advantages that pressure applied on damaged limbs by the shape memory module can be changed and controlled through simple excitation modules, and the defect of pressure lowering of the shape memory module along with time increase can be overcome, so that treatment degree of freedom is increased, treatment effect is improved, and treatment cost is lowered.

A Chinese medicine in the form of tablet or capsule for treating bacillary dysentery is prepared from 8 Chinese-medicinal materials including pulsatilla root, white peony root, phellodendron bark, coptis root, etc through proportioning, decocting, filtering, concentrating, drying, pulverizing and capsulizing or tabletting. Its advantages are high curative effect and quickly taking its effect.

The present invention is anethole trithione liposome with high absorption, high bioavailability and high stability and its preparation. The anethole trithione liposome or anethole trithione liposome precursor is prepared with anethole trithione and phosphatide, cholesterol, supporting agent and other supplementary material. It has phosphatide/medicine weight ratio of 0.1-50, and is prepared through ethanol injecting process, film dispersion process, inverse evaporation process, extruding process or mechanical process. The supporting agent may be sorbitol, mannitol, cane sugar, etc. and has ratio to phosphatide of 0.01-500. The anethole trithione liposome can raise the GSH level of liver, raises the activity of GCS, GSSG-R and GSH-S-TX and lower the activity of GSH-PX, so as to raise the activity of liver cell and increase bile scretion. It is suitable for treating cholecystitis, gall stone and indigestion, and may be used in the assisting treatment of acute and chronic hepatosis.

The invention relates to a wind-cold influenza capsule. Medicine powder in the capsule by parts of weight is 0.5 part to 1.8 parts of ephedra, 0.5 part to 1.8 parts of cassia twig, 0.8 part to 3.6 parts of radices sileris and 0.8 part to 2.5 parts of schizonepeta. The capsule is a combination formed by mixing raw medicines or medicinal slices. 1 part to 2.5 parts of rhizoma seu radix notopterygli, 1 part to 2.5 parts of radix angelicae pubescentis, 0.5 part to 2.6 parts of radix angelicae, 0.8 part to 2.5 parts of tussilago, 0.8 part to 1.8 parts of almond, 1 part to 2.5 parts of lily, 0.8 part to 2.6 parts of radix stemonae, 0.1 part to 0.3 part of aserum and 0.5 part to 1.8 parts of glycyrrhiza can be added into the combination. The wind-cold influenza capsule has obvious effects on slight or severe wind-cold influenza and patients with severe cough, effective rate is more than 99%, and cure rate is more than 95 %. The wind-cold influenza capsule is free of auxiliary materials, cannot scatter qi, has no effects on work and life, and is free of toxic effect, convenient to take and suitable for various wind-cold influenza diseases.

The invention relates to a plant drug compound preparation for treating asthma in children, which comprises water extracts of the following raw materials: 1 to 8 percent of mix-fried ephedra, 1 to 12 percent of almond, 1 to 12 percent of perilla fruit, 1 to 12 percent of radish seed, 1 to 12 percent of earthworm, 1 to 8 percent of peach kernel, 1 to 12 percent of zanthoxylum seed, 1 to 12 percent of baical skullcap root, and 1 to 5 percent of raw licorice; and the preparation of the plant drug compound preparation comprises that: composition of the plant drugs in the proportion is soaked in cold water for 20 to 30 minutes, decocted by intense fire to be boiled, and then decocted by slow fire for 15 minutes, drug juice is poured out, and the operation is repeated, and decoction liquid of the twice is combined to obtain decoction; and the decoction is stood, supernatant fluid is filtered, condensed, cooled naturally, and added with alcohol of which the volume is 1 to 4 times of that of the supernatant fluid, the mixture is precipitated, supernatant fluid is filtered and condensed to thick extract, and the thick extract is added with pharmaceutic adjuvant. The invention also relates to application of the plant drug compound preparation in preparing related medicaments for treating the asthma in children. The plant drug compound preparation has the advantages of high curative effect, no toxic and side effects, low price and the like; and the preparation method is simple, and has low cost and good application prospect.

Disclosed is a cleaning fluid for treating gynaecologic diseases, which is prepared from 19 kinds of Chinese herbs including black nightshade, malva seed, motherwort, corktree bark, flavescent sophora root, cnidium fruit, atractylodes rhizome, Chinese mugwort leafmulberry leaf, carpesium fruit, root of sessile stemona, dandelion, Chinese angelica root and Ligusticum wallichii.

The invention discloses a traditional Chinese medicine for treating chronic pharyngitis. The traditional Chinese medicine is prepared from the following traditional Chinese medicines in parts by weight: 15-20 parts of platycodon grandiflorum, 20-30 parts of liquorice, 15-20 parts of fructus forsythiae, 15-20 parts of mint, 10-20 parts of chrysanthemum, 10-20 parts of honeysuckle, 10-15 parts of sterculia scaphigera, 10-20 parts of radix ophiopogonis and 10-20 parts of radix scrophulariae. The traditional Chinese medicine disclosed by the invention has the advantages of being prepared from pure Chinese herbal medicines, relatively high in treatment effect in treating the chronic pharyngitis, capable of being used for treating both symptoms and root causes, remarkable in treatment effect, free of adverse reaction, small in toxic and side effects, capable of rapidly eliminating clinical symptoms and free of recurrence after the chronic pharyngitis is cured.

The cathartic medicine composition is medicine preparation prepared with aloe, natural indigo, cinnabar and amber as material. The medicine preparation of the present invention has the function of relaxing the bowels, is used in treating constipation, and has fast acting, high curative effect, no toxic side effect. The present invention also provides the quality control method and the quality criterion to make the medicine preparation possess stable and controllable quality.

The invention discloses an intestine positioning preparation of glycyrrhetic acid, glycyrrhetinic acid and salts of glycyrrhetic acid and glycyrrhetinic acid, a preparation method thereof and application thereof. The key point is to wrap glycyrrhetic acid or glycyrrhetinic acid or diammonium glycyrrhizinate and salt compounds thereof in the intestine positioning preparation. The preparation method comprises the following steps of: spraying a liquid medicament onto empty pill cores in a fluidized bed to prepare medicament carrying pill cores, and then wrapping an isolation layer, an enzyme sensitive coating and a pH sensitive coating on the pill cores. The preparation is applied to the preparation of medicaments for treating inflammatory bowel diseases, hepatitis, rheumatoid arthritis, asthma, bronchitis and skin inflammation.

The invention discloses a Maca-lycopene compound preparation and a preparation method thereof. The Maca-lycopene compound preparation comprises the following main materials in parts by weight: 0.002-10 parts of Maca and 0.002-10 parts of lycopene. according to the Maca-lycopene compound preparation, Maca and lycopene are compounded and combined, and the Maca-lycopene compound preparation's curative effects on andropathy and male function are improved owing to the synergistic effect of Maca and lycopene; the Maca-lycopene compound preparation has a certain treatment effect on senile vascular dementia; meanwhile, lycopene is embedded by a one-step embedding method and then is mixed with Maca to prepare the preparation, so that the stability of Maca and lycopene is improved, and the utilization rate of lycopene is increased; pelletization is performed in one step, so that the number of steps is reduced; and embedded lycopene is dispersed more uniformly.

The invention relates to the field of pharmaceutical formulations and in particular to a traditional Chinese medicine for treating bronchitis. The traditional Chinese medicine is characterized by comprising the following raw material medicines in percentage by weight: 4-8% of chrysanthemum, 5-8% of asarum sieboldii, 5-8% of honeysuckle, 3-6% of Japanese ardisia herb, 5-8% of semen brassicae, 4-7% of false aloe, 6-9% of false chinese swertia herb, 6-9% of cacumen biotae, 4-6% of radix scutellariae, 5-7% of rhizoma imperatae, 5-7% of herba patriniae, 3-5% of folium mori, 3-5% of fructus terminaliae billericae, 2-5% of lily, 3-6% of prunella vulgaris, 2-5% of ajowan, 3-5% of codonopsis pilosula and 5-8% of folia perillae acutae, wherein the 18 raw material medicines are dipped in water, and are removed residues after being stewed to obtain filtrate. The traditional Chinese medicine has the advantages of low cost, high effect for treating the bronchitis and no poison or side effects, has the functions of clearing lung, reducing phlegm, checking asthma, tonifying lung and relieving asthma, and is suitable for virtual and empirical asthma.

Disclosed is a Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases, wherein the medicament comprises the following raw material herbs (by weight portion): American ginseng 1-80 parts, notoginseng 1-80 parts, schisandra chinensis 1-50 parts, root of red rooted saliva 5-80 parts, borneol 0. 1-10 parts.